AtlasInfectionsNeglected tropical diseases and malaria

Food-borne trematodiases

4Curable or preventable in mostAI-generated

Food-borne trematodiases: curable in most, but no milestone on recordAI-generated

Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

What's being tested now

2000: 1 trials started2014: 1 trials started2023: 1 trials started2024: 2 trials started20002010202020242

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

Where we are

AI-generated

Food-borne trematodiases are curable or preventable in most cases. Effective antiparasitic drugs—praziquantel for clonorchiasis, opisthorchiasis, and paragonimiasis; triclabendazole for fascioliasis—can cure typical infections. While precise burden trends are not available, well-established knowledge suggests that with access to treatment, severe complications are rare. No single milestone is on record for this disease. Access gaps remain worldwide, but the best available therapy reliably cures most early infections.

Is this disease curable?
Yes, in most cases. Praziquantel or triclabendazole cure typical infections when started early.

Related

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.